3-{2-([5,6]-咪唑-1,10-邻菲咯啉)]}-3′-甲酸-2,2’-联吡啶的合成和晶体结构

Synthesis and crystal structure of 2-{3-(1H-Imdazo[4,5-f] [1,10] phenanthrolin-2-yl)pyridin-2-yl}nicotinic acid

以1,10-邻菲咯啉为原料,经三步反应生成了标题化合物,化合物经1H NMR,MS和X-射线单晶衍射表征.结果表明,化合物晶体为单斜晶系,空间群,P21/c,a=1.24828(16)nm,b=1.18534(15)nm,c=1.37542(16)nm,α=90.00°,β=109.268(4)°,γ=90.00°,V=1.9211(4)nm3,Z=4,Mr=418.41,Dc=1.440g.cm-3,μ=0.097mm-1,F(000)=856,R1=0.0633,wR2=0.1803.CCDC:728109.

A novel compound of 2-{3-（1H-imdazo [ 4, 5-f] [ 1,10 ] phenanthrolin-2-yl） pyridin-2-yl } nicotinic acid was synthesized from 1,10-phenanthrolin through three-step reactions. The compounds were characterized by 1H NMR and MS. The experimental result of X-ray single crystal diffraction analysis revealed that the title compound belongs to monocline system with space groupP21/c,a=1.24828（16）nm,b=1.18534（15）nm,c=1.37542（16）nm,α=90.00°,β=109.268（4）°,γ=90.00°,V=1.9211（4）nm^3,Z=4,Mr=418.41,Dc=1.440g·cm^-3,μ=0.097mm^-1,F（000）=856,R1=0.0633,wR2=0.1803.